Release of necrosis markers and cardiovascular magnetic resonance-derived microvascular perfusion in reperfused ST-elevation myocardial infarction

Husser, Oliver and Bodi, Vicente and Sanchis, Juan and Nunez, Julio and Mainar, Luis and Rumiz, Eva and Lopez-Lereu, Maria P. and Monmeneu, Jose V. and Forteza, Maria J. and Oltra, Ricardo and Riegger, Guenter A. J. and Chorro, Francisco J. and Llacer, Angel (2009) Release of necrosis markers and cardiovascular magnetic resonance-derived microvascular perfusion in reperfused ST-elevation myocardial infarction. THROMBOSIS RESEARCH, 124 (5). pp. 592-600. ISSN 0049-3848,

Full text not available from this repository. (Request a copy)

Abstract

Introduction: The association of the temporal evolution of cardiac necrosis marker release with cardiovascular magnetic resonance-derived microvascular perfusion after ST-elevation myocardial infarction is unknown. Methods: We analyzed 163 patients with a first ST-elevation myocardial infarction and a patent infarct-related artery treated with thrombolysis (67%) or primary angioplasty (33%). Using first-pass perfusion CMR, abnormal perfusion was defined as a lack of contrast arrival into the infarct area in >1 segment. Troponin I. creatine kinase MB and myoglobin were measured upon arrival and at 6, 12, 24, 48 and 96 hours after reperfusion. Results: Abnormal perfusion was detected in 75 patients (46%) and was associated with a larger release of all 3 necrosis markers after reperfusion and higher peak values. This association was observed in the whole group and separately in patients treated with thrombolysis and primary angioplasty. Out of the 3 markers, troponin levels at 6 hours after reperfusion yielded the largest area under the receiver operating characteristic curve for prediction of abnormal perfusion (troponin: 0.69, creatine kinase MB: 0.65 and myoglobin: 0.58). In a comprehensive multivariate analysis, adjusted for clinical, angiographic, cardiovascular magnetic resonance parameters and all necrosis markers, high troponin levels at 6 hours after reperfusion (>median) independently predicted abnormal microvascular perfusion (OR 2.6 95%CI [1.2 - 5.5], p=.012). Conclusions: In ST-elevation myocardial infarction, a larger release of cardiac necrosis markers soon after reperfusion therapy relates to abnormal perfusion. Troponin appears as the most reliable necrosis marker for an early detection of cardiovascular magnetic resonance-derived abnormal microvascular reperfusion. (C) 2009 Elsevier Ltd. All rights reserved.

Item Type: Article
Uncontrolled Keywords: PERCUTANEOUS CORONARY INTERVENTION; TISSUE-LEVEL PERFUSION; CARDIAC TROPONIN-T; BIOCHEMICAL MARKERS; CREATINE-KINASE; PROGNOSTIC-SIGNIFICANCE; CLINICAL CARDIOLOGY; OBSTRUCTION; THROMBOLYSIS; DYSFUNCTION; Cardiac necrosis markers; Troponin; Creatine Kinase MB; Myoglobin; Microvascular perfusion; ST-elevation myocardial infarction; Cardiovascular magnetic resonance
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Dr. Gernot Deinzer
Date Deposited: 03 Sep 2020 04:51
Last Modified: 03 Sep 2020 04:51
URI: https://pred.uni-regensburg.de/id/eprint/28243

Actions (login required)

View Item View Item